Found: 20
Select item for more details and to access through your institution.
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 23, doi. 10.1007/s10549-020-05782-4
- By:
- Publication type:
- Article
Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 560, doi. 10.1111/ajco.13653
- By:
- Publication type:
- Article
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 274, doi. 10.1007/s10147-018-1353-9
- By:
- Publication type:
- Article
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Can we 'feel' the temperature of knowledge? Modelling scientific popularity dynamics via thermodynamics.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0244618
- By:
- Publication type:
- Article
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y
- By:
- Publication type:
- Article
Real‐World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 1, p. 302, doi. 10.1002/cpt.2454
- By:
- Publication type:
- Article
Tissue distribution comparison between healthy and fatty liver rats after oral administration of hawthorn leaf extract.
- Published in:
- Biomedical Chromatography, 2014, v. 28, n. 5, p. 637, doi. 10.1002/bmc.3082
- By:
- Publication type:
- Article
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 699, doi. 10.1007/s40261-023-01294-3
- By:
- Publication type:
- Article
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1
- By:
- Publication type:
- Article
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer.
- Published in:
- Breast Journal, 2020, v. 26, n. 3, p. 368, doi. 10.1111/tbj.13516
- By:
- Publication type:
- Article
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 543, doi. 10.1007/s11523-023-00979-1
- By:
- Publication type:
- Article
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00658-y
- By:
- Publication type:
- Article
Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e749, doi. 10.1002/onco.13684
- By:
- Publication type:
- Article
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1514, doi. 10.1634/theoncologist.2019-0019
- By:
- Publication type:
- Article
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response: Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1558, doi. 10.1093/jnci/djr329
- By:
- Publication type:
- Article
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 9, p. 763, doi. 10.1093/jnci/djr128
- By:
- Publication type:
- Article